BioCorRx (BICX) Invested Capital (2016 - 2025)
Historic Invested Capital for BioCorRx (BICX) over the last 16 years, with Q3 2025 value amounting to -$13.5 million.
- BioCorRx's Invested Capital fell 7240.28% to -$13.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.5 million, marking a year-over-year decrease of 7240.28%. This contributed to the annual value of -$8.1 million for FY2024, which is 15845.13% down from last year.
- Per BioCorRx's latest filing, its Invested Capital stood at -$13.5 million for Q3 2025, which was down 7240.28% from -$13.0 million recorded in Q2 2025.
- In the past 5 years, BioCorRx's Invested Capital ranged from a high of $13.8 million in Q4 2023 and a low of -$13.5 million during Q3 2025
- Its 5-year average for Invested Capital is -$5.7 million, with a median of -$6.9 million in 2024.
- In the last 5 years, BioCorRx's Invested Capital tumbled by 28457.62% in 2022 and then skyrocketed by 38365.07% in 2023.
- Over the past 5 years, BioCorRx's Invested Capital (Quarter) stood at -$4.1 million in 2021, then fell by 18.63% to -$4.9 million in 2022, then surged by 383.65% to $13.8 million in 2023, then plummeted by 158.45% to -$8.1 million in 2024, then crashed by 67.47% to -$13.5 million in 2025.
- Its Invested Capital was -$13.5 million in Q3 2025, compared to -$13.0 million in Q2 2025 and -$11.8 million in Q1 2025.